GlassScriptPhysician profile
Brent Dean Bergen
NPI 1629070693
$600.44
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $63.07 · 2023: $19.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $113.68 | 2019-2020 | |
| Glaxosmithkline, LLC. | $79.11 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.64 | 2019 | |
| Sunovion Pharmaceuticals INC. | $53.06 | 2019 | |
| Csl Behring | $51.76 | 2020 | |
| Genentech USA, INC. | $49.69 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.06 | 2019 | |
| Mylan Specialty L.P. | $25.42 | 2019 | |
| Boston Scientific Corporation | $19.83 | 2023 | Ams 800 Artificial Urinary Sphincter |
| Regeneron Healthcare Solutions, INC. | $16.49 | 2019 | |
| Philips North America LLC | $15.75 | 2019 | |
| Allergan, INC. | $12.98 | 2019 | |
| Electromed, INC. | $12.79 | 2019 | |
| Shire North American Group INC | $12.76 | 2019 | |
| Grifols USA, LLC | $12.47 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.09 | 2019 | |
| United Therapeutics Corporation | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Bergen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.